Beyond the scope of this review, histone acetylation is dynamically controlled by lysine acetyl-transferases (HATs, e.g., CREB-binding protein [CBP]/E1A binding protein p300 [p300]) and histone deacetylases (HDACs) and is aberrant in AML [40−43]. The gene discussed is EP300; the disease is acute myeloid leukemia.